| 000 | 02384 a2200589 4500 | ||
|---|---|---|---|
| 005 | 20250515190023.0 | ||
| 264 | 0 | _c20110203 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1573-0646 | ||
| 024 | 7 |
_a10.1007/s10637-009-9324-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoy Choudhury, Subhasree | |
| 245 | 0 | 0 |
_aSynergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplification. _h[electronic resource] |
| 260 |
_bInvestigational new drugs _cDec 2010 |
||
| 300 |
_a812-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAngiogenesis Inducing Agents _xmetabolism |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBenzenesulfonates _xpharmacology |
| 650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Shape _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p21 _xmetabolism |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 |
_aGene Amplification _xdrug effects |
| 650 | 0 | 4 |
_aGenistein _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 | _aMyeloid Cell Leukemia Sequence 1 Protein |
| 650 | 0 | 4 |
_aNeuroblastoma _xdrug therapy |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-myc _xgenetics |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 |
_aTelomerase _xmetabolism |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 650 | 0 | 4 |
_abcl-2-Associated X Protein _xmetabolism |
| 700 | 1 | _aKarmakar, Surajit | |
| 700 | 1 | _aBanik, Naren L | |
| 700 | 1 | _aRay, Swapan K | |
| 773 | 0 |
_tInvestigational new drugs _gvol. 28 _gno. 6 _gp. 812-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10637-009-9324-7 _zAvailable from publisher's website |
| 999 |
_c19174045 _d19174045 |
||